Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.78 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 7/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.46 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.46 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL6130794 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL6130796 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL4775848 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| D-Leucine SCHEMBL4958590 | 1.00 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL28146797 | 0.96 | SLC7A5 (0.72) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL27607014 | 0.92 | SLC7A5 (0.67) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL2496434 | 0.92 | SLC7A5 (0.67) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL27563977 | 0.91 | SLC7A5 (0.64) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL998944 | 0.89 | SLC7A5 (0.90) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL998945 | 0.89 | SLC7A5 (0.90) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3737420-A2 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2020-11-18 | — | — | EP | disclosed |
| US-10456736-B2 | Method and apparatus for purification and treatment of air | PALOZA LLC (US) | 2019-10-29 | — | — | US | disclosed |
| WO-2019136487-A2 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2019-07-11 | — | — | WO | disclosed |
| CN-107029517-A | Purification and the method and apparatus of processing air | 朱潮权 | 2017-08-11 | — | — | CN | disclosed |
| US-20170106333-A1 | Method and Apparatus for Purification and Treatment of Air | PALOZA LLC | 2017-04-20 | — | — | US | disclosed |
| CN-104610454-A | HSA-related compositions and methods of use | MEDIMMUNE LLC | 2015-05-13 | — | — | CN | disclosed |
| CN-102781960-B | HSA-related compositions and methods of use | MEDIMMUNE LLC | 2014-12-10 | — | — | CN | disclosed |
| EP-2729570-A2 | REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS | Qiagen GmbH (DE) | 2014-05-14 | — | — | EP | disclosed |
| CN-101522706-B | Telomerase reverse transcriptase fusion protein, nucleotides encoding same, and uses thereof | ANGELETTI P IST RICHERCHE BIO | 2013-09-04 | — | — | CN | disclosed |
| WO-2013004710-A2 | REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2013-01-10 | — | — | WO | disclosed |
| EP-1957458-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | Elan Pharmaceuticals Inc. (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007064914-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | ELAN PHARMACEUTICALS, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| CN-1151761-A | Subtilisin BPN' variants with reduced adsorption and increased hydrolysis | PROCTER & GAMBLE (US) | 1997-06-11 | — | — | CN | disclosed |
| EP-0476022-A1 | CRYSTALLINE R-H-GM-CSF AND METHOD FOR THE PREPARATION | SCHERING CORPORATION (US) | 1992-03-25 | — | — | EP | disclosed |
| WO-1990015151-A1 | CRYSTALLINE R-H-GM-CSF AND METHOD FOR THE PREPARATION | SCHERING CORPORATION (US) | 1990-12-13 | — | — | WO | disclosed |
| EP-0402070-A1 | Crystalline r-h-GM-CSF and method for its preparation | SCHERING CORPORATION (US) | 1990-12-12 | — | — | EP | disclosed |
| CN-85101907-A | The manufacturing of single segment dominent human r gamma-interferon | — | 1987-01-10 | — | — | CN | disclosed |